On Wednesday, Berry Plastics Group Inc (NYSE:BERY)’s shares declined -0.47% to $33.72.
Berry Plastics Group, Inc. ( BERY) declared that Berry Plastics Corporation (the “Issuer”), Berry Group’s wholly owned partner, issued $700,000,000 in aggregate principal amount of 5.125 percent Second proceeding Senior Secured Notes due 2023 following an indenture, dated as of June 5, 2015, by and among the Issuer, the guarantors named therein and U.S. Bank National Association, as trustee.
In addition, following a formerly declared cash tender offer and consent solicitation (the “Offer”) by the Issuer, with respect to any and all of the Issuer’s outstanding 9.75 percent Second Precedingity Senior Secured Notes due 2021 (the “Notes”) issued under an indenture dated as of November 19, 2010 (the “Indenture”), about 63 percent of the outstanding Notes had been tendered as of 5 p.m., New York City time, on June 4, 2015, the expiration of the consent payment deadline (the “Consent Date”). The consents received exceeded the number needed to approve the projected amendments (the “Projected Amendments”) to the Indenture and the Issuer has elected to exercise its right to accept for early payment all of the Notes validly tendered preceding to the Consent Date. Each of the holders who validly tendered its Notes and delivered consents proceeding to the Consent Date will receive the total consideration of $1,102.50, which comprises $1,072.50 as the tender offer consideration and $30.00 as a consent payment. In addition, accrued interest up to, but not counting, the applicable payment date of the Notes will be paid in cash on all validly tendered and accepted Notes. The Issuer presently anticipates these payments will be made on June 5, 2015. The complete terms and conditions of the tender offer and consent solicitation for the Notes are detailed in the Offer to Purchase and Consent Solicitation Statement dated May 21, 2015 and the related Consent and Letter of Transmittal (the “Tender Offer Documents”).
Berry Plastics Group, Inc. manufactures and distributes plastic consumer packaging and engineered materials in North America and internationally. The company operates through four segments: Rigid Open Top, Rigid Closed Top, Engineered Materials, and Flexible Packaging. It offers rigid packaging products, counting containers; foodservice items, which comprise thermoformed polypropylene and injection-molded plastic drink cups; closures and overcaps; bottle and prescription containers, such as polyethylene and polyethylene terephthalate bottles, in addition to decorated bottles; and tubes.
TerraForm Power Inc (NASDAQ:TERP)’s shares dropped -1.96% to $38.49.
TerraForm Power Inc (TERP) an owner and operator of clean energy power plants, declared the acquisition of a 9 MW net ownership stake in a portfolio of operating distributed solar power plants from Duke Energy Renewables, a commercial business unit of Duke Energy, the nation’s largest electric power holding company.
Combined with the 23 MW net ownership stake in this portfolio previously acquired from Integrys, TerraForm Power’s total ownership in these 48 plants represents 32 MW. Terms of the Duke sale were not disclosed.
TerraForm Power, Inc. owns and operates solar and wind generation assets serving utility, commercial, and residential customers. As of February 20, 2015, its portfolio compriseed of solar and wind projects located in the United States, Canada, the United Kingdom, and Chile with an aggregate nameplate capacity of 1,507.3 megawatt. The company was formerly known as SunEdison Yieldco, Inc. and changed its name to TerraForm Power, Inc. in May 2014. The company was founded in 2014 and is based in Bethesda, Maryland. TerraForm Power, Inc. is a partner of SunEdison, Inc.
At the end of Wednesday’s trade, Clovis Oncology Inc (NASDAQ:CLVS)‘s shares surged 1.22% to $88.56.
Clovis Oncology Inc (CLVS) declared updated findings from its Phase 2 clinical study of rociletinib (CO-1686), the Company’s novel, oral, targeted covalent (irreversible) mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) for the treatment of non-small cell lung cancer (NSCLC) in patients with initial activating EGFR mutations, in addition to the dominant resistance mutation T790M. These data from the TIGER-X trial are being presented recently in an oral presentation (Abstract #8001) at the 2015 American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. It is developing three product candidates which comprise Rociletinib, an oral epidermal growth factor receptor and mutant-selective covalent inhibitor that is in advanced clinical development for the treatment of non-small cell lung cancer; Rucaparib, an oral inhibitor of poly polymerase, which is in advanced clinical development for the treatment of ovarian cancer; and Lucitanib, an oral inhibitor of the tyrosine kinase that is in Phase II development for the treatment of breast and lung cancers.
Qorvo Inc (NASDAQ:QRVO), ended its Wednesday’s trading session with -0.10% loss, and closed at $77.88.
Qorvo Inc (QRVO) is planned to declare its fourth quarter financial results on Monday after the market closes. According to Estimize, expectations point towards a moderate quarter-over-quarter decline in earnings.
For the current quarter, the Street is modeling consensus earnings of $0.86 per share on revenue of $621.27 million. The crowd is more bullish and is projecting consensus earnings of $0.93 per share on revenue of $629.8 million.
While current estimates imply a marked enhance from the earnings of $0.12 per share and revenue of $256 million that RF Micro Devices posted a year ago, they also bring a double-digit decline from last quarter’s earnings of $1.18 per share on revenue of $741 million.
Qorvo, Inc. provides technologies and radio frequency (RF) solutions for mobile, infrastructure, defense, and aerospace applications in the United States and internationally. The company operates through Mobile Products, and Infrastructure and Defense Products segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
